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Abstract
Bangham was first to develop these spherical-shaped nano-vesicles called 
liposomes in the early 1960s. Today, liposomes have emerged as crucial tools for 
bettering the delivery of drugs that majorly includes-antifungal drug, peptide hor-
mones, enzymes, vaccines antimicrobial agents, drugs against cancer, and genetic 
materials. Following the different manufacturing practices and versatile properties 
liposomes can be categorized in various parameters of size, charge, poly-dispersity 
index, encapsulation efficiency, solubility properties, and lamellarity. Alteration in 
such parameters elevates the loading and bioavailability of a drug by giving more 
clear target specification, desired or controlled release. This bibliographic chapter 
provides a comprehensive overview of methods for the preparation of liposomes 
with other perspectives that majorly includes—physio-chemical characteristics, 
dosage regimen, advantages over other delivery systems, approved liposomal based 
drugs and other ongoing drugs in clinical trials. It will help researchers to break-
through more structurally successful delivery vehicles depending upon their various 
physic-chemical properties.
Keywords: liposomes, particle size, zeta potential, polydispersity index, 
encapsulation efficiency, methods of preparation and bioavailability
1. Introduction
Liposomes can be microscopically examined as the vesicle with spherical 
structure that comprises one or more bilayer lipid in the aqueous core part of a 
shell. Liposomes are widely used in the delivery of variety of drugs depending upon 
its various physic-chemical characteristics. Design and development of liposomes 
are classified in many ways among which thin film hydration method is the most 
globally accepted procedure. Liposmes formation occurs when lipids are incorpo-
rated into water or buffer solution under continuous stirring, that in return forms 
the spherically shaped vesicles termed as liposomes. There are many methods to 
develop liposomes among which thin film hydration method is most common. 
Recently, lipid film hydration method was used to develop a multilamellar vesicle 
(MLV) loaded with curcumin (CUR) and Rhodamine B (RhB), [1] as a successful 
drug delivery approach. Phospholipids and cholesterol are the major components 
used in the development of liposomes (Figure 1). Where bilayer lipid composes of 
a hydrophilic head group, i.e., phospholipid and a hydrophilic tail group. Where 
phospholipids can easily penetrate and localize in the skin thus increases the overall 
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bioavailability in case of many dermal formulations whereas, cholesterol not only 
increases microviscosity of the bilayer but also defines the stability and rigidity of 
the formulation [2].
There are many routes to administer liposomes containing drugs, i.e., pulmonary, 
ocular, intramuscular, intravenous, topical, nasal and oral. Liposomes can be deliv-
ered in many ways involving sprays, capsules, ointments, creams, solutions, etc. for 
curing various disseases: bacterial, fungal, ocular, vaccines, fibrinolysis, endocrine, 
arthritis, asthma, diabetes, diseases of immune system, herpes, analgesics, topical 
anesthesia and even cancer [3].
Based on different parameters, liposomes are further classified depending 
upon method of preparation, structural parameters, biochemistry, cosmetics and 
medicine composition, and application in biology. Phospholipids can be from 
natural sources such as soya bean, egg yolk and olive oil. Depending upon vari-
ous characteristics liposomes can be categorized on the basis of various physical 
parameters such as—pH, temperature, ionic charges, immunogenicity and 
stability.
In a recent study performed in 2019, it is revealed that the concentration of 
phospholipids and cholesterol variates the protein binding of the formulation [4].
Most commonly employed phospholipids in the formulation of liposomes are: 
phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylinositol (PI), 
phosphatidylethanolamine (PE), dipalmitoyl phosphatidylserine1,2dioleoylsnglyc
ero3phosphoserine, dipalmitoylphosphatidylcholine (DPPC), distearoylphosphati-
dylcholine (DSPC), dioleoylphosphatidylethanolamine (DOPE) [5].
1.1 Composition of liposomes
A. Phospholipids
1. Derived from natural sources:
• Phosphatidylcholine
• Phosphatidylserine
• Phosphatidylethanolamine
Figure 1. 
Liposome molecule with lipid bilayer.
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2. Synthetic phospholipids:
• Disloyal phosphatidylethanolamine
• Disloyal phosphatidylcholine
B. Cholesterol
Cholesterol are optimized to be used in the formulation of liposomes up to a wide 
range with a molar ratios 1:1 or 2:1 against phospholipids. Cholesterol defines a stra-
tegic role in liposome composition; although, the adequate quantity to be used in the 
formulation has not been yet clarified. Thus, we can optimize lipids and cholesterol 
ratio, to prepare stable and controlled drug release vehicles (Figures 2 and 3) [6].
2. Physio-chemical properties
See Tables 1–3.
3. Applications of liposomes
Role of liposome in drug delivery:
• Selective & passive targeting.
• It increases the overall therapeutic index and efficacy of a liposomal 
formulation.
Figure 2. 
Hydrophilic and lipophilic terminals of lipid.
Figure 3. 
Inner and outer structure of liposome.
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Characterization parameters Analytical method/instrument
Phospholipid concentration Barlett assay, Stewart assay, HPLC
Concentration of cholesterol By HPLC
Phopholipid peroxidation UV absorbance, iodometric, GLC
Table 2. 
Chemical characterization [6].
• Due to the encapsulation of drug, overall stability is increased and reduced the 
adverse effects of encapsulated drug.
• It helps to improve the pharmacokinetic processes by increasing the circulation 
lifetime, decreasing elimination and toxic effects thus elevating the overall 
bioavailability of a drug [7].
• Active targeting can also be achieved by coupling with the site-specific 
ligands.
3.1 Other advantages of using liposomes
• Biodegradability
• Efficient control of the release
• Resemblance to natural membrane structures
• Increased targeting prospects
Characterization parameters Analytical method/instrument
Mean vesicle size and size distribution 
(submicron and micron range)
Zetasizer
Vesicle shape and surface morphology Transmission electron microscopy
Electrical surface potential and surface pH Zetasizer & pH measurement device
Surface charge free Flow electrophoresis
Phase behavior Differential scanning calorimetry (DSC)
Lamellarity Freeze-fracture electron microscopy
Percent of free drug/percent capture Minicolumn centrifugation, ion-exchange 
chromatography, radiolabelling
Table 1. 
Physical characterization [6].
Characterization parameters Analytical method/instrument
Sterility aerobic or anaerobic cultures Sterility aerobic or anaerobic cultures
Pyrogenicity Limulus amebocyte lysate (LAL) test
Animal toxicity By pathology and histology
Table 3. 
Biological characterization [6].
5Liposome—A Comprehensive Approach for Researchers
DOI: http://dx.doi.org/10.5772/intechopen.93256
• Biocompatibility
• Biodegradable
• Liposomes are able to provide both aqueous “milieu internee” and the lipo-
philic environment in a single system
• It helps in protecting the encapsulated drug.
• Method of preparation is easy and has no such complicated or expensive 
procedures involved
• Facilitates both active and passive targeting.
• No toxicity in heart as it does not accumulates in the heart.
• Intercepts the oxidation of drug
• Chelation therapy in case of of heavy metal poisoning
• Diagnostic imaging of tumors
• In enzyme replacement therapy
• Study of membranes
• In gene delivery
• As drug delivery carriers
• In multidrug resistance
• In immunology
• In cosmetology (Table 4)
Category Application utilized
In parasitic diseases After IV injection liposomes are comfortly digested by phagocytic cells in the 
body and hence considered as one of the best vehicle to dispatch cargo into 
macrophages
Anticancer therapy Liposomes are effective for the cells not only in tumors but also in the 
gastrointestinal mucosa
Other medical 
applications
These liposomes are sterically stabilized vesicles and are long circulating micro-
reservoirs or tumor (or site of inflammation and infection) targeting vehicles
In bioengineering Fragments of siRNA and DNA are delivered with the help of modern genetic 
engineering and gene recombinant technology
In vaccination Liposomes are considerably used in proper vaccination due its fine active targeting
In agro-food industry Due to its versatile physio-chemical properties lipids are extensively manufactured 
and used in large scale up sectors
Table 4. 
Applications of liposomes [6].
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4. Methods of preparation
See Figure 4.
4.1 Thin film hydration method
This is one of the widely used methods for the preparation of liposomes. As 
it has no such complicated steps involved in it. Multilamellar vesicles (MLV) are 
prepared by solubilizing natural or synthesized phospholipid in chloroform, dichlo-
romethane, ethanol or in a mixture of chloroform and methanol in a ratio of 3:1 v/v; 
2:1 v/v or 9:1 v/v. A homogeneous thin film forms when this mixture is revolved and 
dried in a rota-evaporator under vacuum at a temperature around 45–60°C. Layes is 
kept under nitrogen drying for overnight. Next, comes the hydration process where 
completely dried thin film is hydrated using aqueous phase—phosphate buffer 
solution of pH 7.2 for 1–2 h at 60–70°C.
This kind of procedure can be applied to almost any kind of lipid mixtures, but 
has some drawbacks that majorly includes—low encapsulation space, a bit difficult 
to scale up and layer formed are not always homogeneous thus shows heterogeneous 
size distribution during later physio-chemical examination of liposomes through 
zetasizer.
4.2 Injection methods
4.2.1 Ether injection method
Here, the lipid mixture is dissolved in ether or diethyl ether under continuous 
stirring that is later injected into a PBS or aqueous phase. Which under injection 
pressure causes the removal of almost all organic solvent that ultimately forms 
liposomes. This method also suffers with the heterogeneous liposomal formulation 
defect.
Figure 4. 
General representation for method of preparation of liposome.
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4.2.2 Ethanol injection method
In ethanol injection method the lipid mixture is dissolved in ethanol under contin-
uous stirring that is later injected into a preheated TRIS-HCl buffer or distilled water. 
Hydrophobicity and hydrophilicity of a drug accounts for drug intake in a liposomal 
vesicle. It has an advantage of using non-toxic and ethanol and is also easily scalable.
4.3 Sonication method
It is the most widely accepted method to develop small unilamellar vesicles 
(SLV). SLV are prepared by solubilizing natural or synthesized phospholipid in 
chloroform, dichloromethane, ethanol or in a mixture of chloroform and methanol 
in a ratio of 3:1 v/v; 2:1 v/v or 9:1 v/v. A homogeneous thin film forms when this 
mixture is revolved and dried in a rota-evaporator under vaccum at a temperature 
around 45–60°C. Layes is kept under nitrogen drying for overnight. Next, comes 
the hydration process where completely dried thin film is hydrated using aquous 
phase—phosphate buffer solution of pH 7.2 for 1–2 h at 60–70°C. Further the bath 
sonicator is used to transform the size of vesicles. Lastly, liposomes are centrifuged 
in order to remove the titanium particles that might got added due to overheating in 
sonication process. Less encapsulation space is the major drawback of such vesicles.
4.4 High-pressure extrusion method
Liposomes are prepared by solubilizing natural or synthesized phospholipid in 
chloroform, dichloromethane, ethanol or in a mixture of chloroform and methanol 
in a ratio of 3:1 v/v; 2:1 v/v or 9:1 v/v. A homogeneous thin film forms when this 
mixture is revolved and dried in a rota-evaporator under vacuum at a temperature 
around 45–60°C. Layes is kept under nitrogen drying for overnight. Next, comes 
the hydration process where completely dried thin film is hydrated using aqueous 
phase—phosphate buffer solution of pH 7.2 for 1–2 h at 60–70°C. In addition, these 
lipoosmes are passes through high pressure extruder for 10 cycles in order to obtain 
more uniform and stable liposomes.
4.5 Reverse-phase evaporation method
Here, the lipid mixture is dissolved in organic solvents ether or diethyl ether 
or a mixture of diethyl ether and chloroform (1:1 v/v); a mixture of methanol-
chloroform (1:2 v/v) under continuous stirring that is later injected into a PBS 
or aqueous phase comprising citric-Na2HPO4 to improve the overall efficacy of a 
formulation. Which under injection pressure causes the removal of organic solvent 
that ultimately leads to the formation of liposomes. This method also suffers with 
the heterogeneous liposomal formulation defect. Organic solvent is then dried using 
rota-vapor instrument thus forming homogeneous liposome. The major disad-
vantage of this procedure is the leftover of remaining organic solvent in the final 
formulation also faces difficulty in scale up procedures.
4.6 Calcium-induced fusion method
Here acidic phospholipids are used to prepare SUV by following the thin film 
hydration process followed on with the addition of calcium that causes fusion 
to form MLV. Final addition of ethylenediaminetetraacetic acid (EDTA) to MLV 
results in the formation of large unilamellar vesicles LUV.
Molecular Pharmacology
8
4.7 Dehydration-rehydration method
Liposomes are prepared by using the sonication method as explained in Section 
4.3. Developed liposomes are freeze dried overnight where the formation of multi-
lamellar vesicles occurs when dry powder gets controlled rehydration.
4.8 Freeze-thaw method
Liposomes are prepared by using thin film hydration method as explained in 
Section 4.1. Developed liposomes are freeze dried overnight and is then thawed 
Drugs liposome formulation Method Type of 
liposome
Antifungal drugs
Amphotericin B Thin-film hydration method MLV
Clotrimazole Rotary evaporation method MLV
Fluconazole Thin film hydration method MLV
Analgesic drugs
Ketorolac tromethamine Thin-film hydration method MLV
Antibiotic drugs
Amikacin Reverse phase evaporation method MLV, LUV
Mafenide acetate Solvent evaporation and microencapsulation MLV SUV
Antifibrinolytic drugs
Tranexamic acid Chloroform film and sonication method SUV
Drugs against cancer
5-Fluorouracil Lipid-film hydration method, extrusion, 
ethanol injection and reverse phase 
evaporation method
MLV, LUV, 
SUV MLV, 
LUV
Vinblastine sulphate Thin-film hydration method and sonication MLV SUV
Tamoxifen Thin-film hydration method MLV
Bis-demethoxy curcumin analogue Thin-film hydration method and sonication MLV SUV
Doxorubicin Lipid-film hydration method and extrusion MLV
Hormone drugs
Cyproterone acetate Thin-film hydration method MLV
Immunosuppressive drugs
Sirolimus Thin-film hydration method MLV
Tacrolimus (Fk-506) Thin-film hydration method MLV
Ophthalmic drugs
Brimonidine tartrate Thin-film hydration method and sonication MLV SUV
Acetazolamide Reverse phase evaporation and thin-film 
hydration method
MLV, LUV 
MLV
Potential drugs as oral insulin
Sodium glycocholate and metformin 
hydrochloride
Reverse phase evaporation and thin-film 
hydration method
MLV, LUV 
MLV
Vaccines
Tetanus toxoid diphtheria toxoid Reverse phase evaporation method MLV, LUV
Table 5. 
Methods for the preparation of liposomal formulation to deliver drugs [2].
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in order to govern the ionic strength and phospholipid concentration of the final 
liposomal formation. Physical disruption of lamellar structure occurs due to freeze-
thaw of liposomal formulation giving it a final ionic structure.
4.9 Microfluidization
Boltic et al. was the first to introduce such method for the preparation of lipo-
somes. Here liposomes are prepared using thin film hydration method as explained 
in Section 4.1, which is then sonicated and microfluidized in order to obtain partial 
homogenization. This method has its wide application in industrial formulation of 
liposomes.
4.10 Supercritical fluids (SCF)
Supercritical fluids (SCF) were introduced to replace toxic organic solvents for 
the preparation of liposomes. Supercritical carbon dioxide is the most widely used 
supercritical fluid as it has many advantages over conventionally used organic sol-
vents such as—it is not flammable, can be recycled, non-toxic, can be comparatively 
easily removed from the solvents, requires moderate temperature and also exclude 
the product degradation in inert surroundings. Karn et al. experimented and 
explained the comparative study between thin film hydration method and super-
critical fluids using method evaluating the non toxicity and better field approaches 
in term of using super critical fluids for the formulation of liposomes (Table 5).
5. Mechanism of liposomal formulation
• Phospholipids shows affinity for polar molecules as well as for aqueous phase 
due to a hydrophobic tail, that has 2 fatty acids which are made up of 10–24 C 
atoms comprising of 0–6 double bonds in every chain [8].
• In a phospholipid molecule the polar portion connects with a polar environ-
ment of a aqueous medium.
• Phospholipids arrange layers of lipids in close alignment in a planer bilayer 
sheet. Sufficient amount of energy is required for this planar arrangement 
(sonication, homogenization, heating, etc.) (Figure 5).
6. Evaluation
6.1  Morphological and physicochemical characterization of 
liposomal-formulation
The average size, size distribution, and zeta potential shall be determined by 
zetasizer.
Transmission electron microscopy is used to study the shape and surface mor-
phology of a liposomal structure.
6.2 In vitro performance evaluation and stability studies
Stability studies: stability studies shall be conducted to assess the shelf-life of 
product as per ICH guidelines.
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MTT [3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay to 
evaluate the in-vitro cytotoxicity of the developed formulation.
FACS (fluorescence assisted cell sorting) is used to quantify the cell 
uptake study.
7. Marketed liposomal formulations
See Tables 6 and 7.
Figure 5. 
Mechanism of liposome formation.
Marketed product Drug used Target diseases Company
AlecTM Dry protein free powder 
of DPPC PG
Expanding lung 
diseases in babies
Britannia Pharm, UK
VentusTM Prostaglandin E1 Systemic inflammatory 
diseases
The liposome company, 
USA
Topex Br Terbutaline sulphate Asthma ozone USA
DoxilTM or 
CaelyxTM
Doxorubicin Kaposi’s sarcoma SEQUUS, USA
Novasome Smallpox vaccine Smallpox Novavax USA
EvacetTM 
Doxorubicin
Doxorubicin Metastatic breast 
cancer
The Liposome 
Company, USA
Fungizone® Amphotericin B Fungal infections Leishmaniasis
Depocyt Cytarabine Cancer therapy Skye Pharm USA
Doxil® Doxorubicin HCl Refractory ovarian 
cancer
ALZA, USA
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8. Conclusions
Liposomes evolved as an extraordinary tool or micro-engineered membranes 
for the delivery of drugs because of their minimum toxicity and flexibility that can 
be tailored for various desirable intentions. This unparalleled delivery approach 
can be used for almost every drug or active pharmaceutical ingredient despite of its 
varied physicochemical properties and route of administration. Extensive uses of 
liposome in the delivery of drugs can be starched further by researchers, medical 
representatives and in scale-up processes in order to develop desired modification 
and better delivery approaches by holding the promising physio-chemical proper-
ties and pharmacokinetics (absorption, distribution, metabolism, and elimination) 
involved with liposomes, as described in the chapter.
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Product Manufacturer Liposomes and key ingredients
Formule Liposome 
Gel
Formule Liposome Gel Payot 
(Ferdinand Muehlens)
(Thymoxin) hyaluronic acid
Symphatic 2000 Biopharm GmbH Thymus extract vitamin A palmitate
Niosomes Lancome (L’Or’eal) Glyceropolyether with moisturizers
Inovita Pharm/Apotheke Thymus extract, hyaluronic
Future Perfect Skin 
Gel
Estee Lauder TMF, Vitamins E, A palmitate, 
cerebroside ceramide
Flawless finish Elizabeth Arden Liquid make up
Eye Perfector Avon Soothing cream to reduce eye
Nactosomes Lancome (L’Or’eal) Vitamins
Efect du Soleil L’Or’eal Tanning agents in liposomes niosomes 
lancome
Natipide II Nattermann PL Liposomal gel for do-it yourself
Table 7. 
Liposomal cosmetic formulations present in the market [10].
Marketed product Drug used Target diseases Company
AmphotecTM Amphotericin B fungal infections, 
leishmaniasis
SEQUUS, USA
Table 6. 
Liposomal formulations present in the market [9].
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